AKTX:NASDAQ
Akari Therapeutics PLC
$15.84
arrow_upward
+5.71%(+0.86) 1D
$15.52
arrow_downward
-2.02% (-0.32)bedtimeAfter hours
Closed: Jun 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKTX...
Open
$14.99
High
$16.11
Low
$14.41
Mkt. cap
18.12M
Avg. vol.
1.55M
Volume
0.00
52-wk high
$55.60
52-wk low
$3.02
EPS
-$424.00
Beta
1.33
Shares outstanding
1.14M
No. of employees
5
Open
$14.99
High
$16.11
Low
$14.41
Mkt. cap
18.12M
Avg. vol.
1.55M
Volume
0.00
52-wk high
$55.60
52-wk low
$3.02
EPS
-$424.00
Beta
1.33
Shares outstanding
1.14M
No. of employees
5
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to AKTX in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AKTX in the last 3 months.
Highest
Current $15.84
$27.00 (+70.45%)
Average
$27.00 (+70.45%)
Lowest
$27.00 (+70.45%)
News stories
From sources across the web
Stock Titan
·
9 hours ago
Large share issuance and governance votes ahead at Akari (NASDAQ: AKTX) 2026 AGM
Stock Titan
·
16 hours ago
Inside Akari’s push for new ADC payloads to tackle KRAS cancers
About Akari Therapeutics PLC
CEO-
Employees5
Founded2004
HeadquartersTampa, Florida, United States
SectorBiotechnology
Websiteakaritx.com
AI content may include mistakes. Learn more